Literature DB >> 10534541

A review of gastrointestinal manifestations of systemic lupus erythematosus.

S M Sultan1, Y Ioannou, D A Isenberg.   

Abstract

In this review, we analyse critically the effects of systemic lupus erythematosus (SLE) on the gastrointestinal (GI) tract from mouth to anus, attempting to distinguish the features that are most likely to be due to therapy. GI manifestations of SLE include mouth ulcers, dysphagia, anorexia, nausea, vomiting, haemorrhage and abdominal pain. GI vasculitis is usually accompanied by evidence of active disease in other organs. Early recognition of the significance of these symptoms offers the best opportunity to improve the symptoms and to aid long-term survival.

Entities:  

Mesh:

Year:  1999        PMID: 10534541     DOI: 10.1093/rheumatology/38.10.917

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  37 in total

Review 1.  Celiac disease and autoimmunity in the gut and elsewhere.

Authors:  Susan H Barton; Joseph A Murray
Journal:  Gastroenterol Clin North Am       Date:  2008-06       Impact factor: 3.806

2.  Abdominal manifestations in childhood-onset systemic lupus erythematosus.

Authors:  O Richer; T Ulinski; I Lemelle; B Ranchin; C Loirat; J C Piette; P Pillet; P Quartier; R Salomon; B Bader-Meunier
Journal:  Ann Rheum Dis       Date:  2006-07-03       Impact factor: 19.103

3.  Endoscopic and radiographic features of gastrointestinal involvement in vasculitis.

Authors:  Akira Hokama; Kazuto Kishimoto; Yasushi Ihama; Chiharu Kobashigawa; Manabu Nakamoto; Tetsuo Hirata; Nagisa Kinjo; Futoshi Higa; Masao Tateyama; Fukunori Kinjo; Kunitoshi Iseki; Seiya Kato; Jiro Fujita
Journal:  World J Gastrointest Endosc       Date:  2012-03-16

Review 4.  Gastrointestinal and Hepatic Disease in Systemic Lupus Erythematosus.

Authors:  Brian N Brewer; Diane L Kamen
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

5.  Coexistence of Crohn's disease in a patient with systemic lupus erythematosus.

Authors:  Konstantinos H Katsanos; Paraskevi V Voulgari; Anna Goussia; Panagiotis Oikonomou; Dimitrios K Christodoulou; Alexandros A Drosos; Epameinondas V Tsianos
Journal:  Rheumatol Int       Date:  2012-01-15       Impact factor: 2.631

Review 6.  Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review.

Authors:  Qiang Lin; Man Zhang; Hanyun Tang; Yunyan Shen; Yun Zhu; Qinying Xu; Xiaozhong Li
Journal:  Rheumatol Int       Date:  2019-08-03       Impact factor: 2.631

7.  Protein-losing enteropathy associated with systemic lupus erythematosus: response to cyclophosphamide.

Authors:  Gláucio R Werner de Castro; Simone Appenzeller; Manoel B Bértolo; Lílian Tereza Lavras Costallat
Journal:  Rheumatol Int       Date:  2004-07-13       Impact factor: 2.631

8.  Systemic lupus erythematosus associated with recurrent lupus enteritis and peritonitis.

Authors:  Yuko Kaneko; Michito Hirakata; Akira Suwa; Shinji Satoh; Takaki Nojima; Yasuo Ikeda; Tsuneyo Mimori
Journal:  Clin Rheumatol       Date:  2004-05-15       Impact factor: 2.980

9.  The use of tacrolimus for recurrent lupus enteritis: a case report.

Authors:  Tsuyoshi Shirai; Yasuhiko Hirabayashi; Ryu Watanabe; Yumi Tajima; Hiroshi Fujii; Naruhiko Takasawa; Tomonori Ishii; Hideo Harigae
Journal:  J Med Case Rep       Date:  2010-05-24

10.  Lymphocytic enterocolitis in systemic lupus erythematosus.

Authors:  Mohamed O Hegazi; Salem F Owayed; Mohamed Mourou; Munish Joneja; Anant Mashankar
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.